# An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients

> **NCT02173951** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 64 (estimated)

## Conditions studied

- Beta Thalassemia Major

## Interventions

- **DRUG:** Deferiprone

## Key facts

- **NCT ID:** NCT02173951
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2015-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02173951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02173951, "An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02173951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*